Dna Group (T.R.) Ltd (DNA.TA)

ILA 116.2

(6.02%)

Market Cap (In ILA)

143.11 Million

Revenue (In ILA)

306 Thousand

Net Income (In ILA)

-1.17 Million

Avg. Volume

97.33 Thousand

Currency
ILA
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
59.0-118.5
PE
-
EPS
-
Beta Value
0.173
ISIN
IL0011038523
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Tal Marom
Employee Count
-
Website
-
Ipo Date
2007-12-04
Details
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.